Stock listing
A2QJV6 Stock Price, News, Filings & Events — Vivoryon Therapeutics N.v.
Selected listing: A2QJV6 · LS · EUR · DE
This page tracks Vivoryon Therapeutics N.v.'s A2QJV6:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2QJV6:LS. A2QJV6:LS is the stock-level entry point for investors researching Vivoryon Therapeutics N.v., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2QJV6:LS
- Asset type
- Stock
- Market cap
- $39.3M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- LS
- Currency
- EUR
Vivoryon Therapeutics N.v. A2QJV6:LS stock context
This page tracks Vivoryon Therapeutics N.v.'s A2QJV6:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2QJV6:LS. A2QJV6:LS is the stock-level entry point for investors researching Vivoryon Therapeutics N.v., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Vivoryon Therapeutics N.v.
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
August 18, 2026
Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for...
July 22, 2026
Vivoryon Therapeutics N.V. to Report Q1 2026 Financial Results on June 11, 2026
June 8, 2026
Vivoryon Therapeutics N.V. Reports Full Year 2025 Financial Results and Provides Business Update
April 23, 2026
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026
April 15, 2026
Vivoryon Therapeutics N.v. earnings calls
Research Vivoryon Therapeutics N.v.
Vivoryon Therapeutics N.v. investor report
Review AI stock analysis and investor report context for A2QJV6:LS.
Vivoryon Therapeutics N.v. company profile
View the public company page for Vivoryon Therapeutics N.v. on 6ix.
Vivoryon Therapeutics N.v. news
Read company news and market updates connected to Vivoryon Therapeutics N.v..
Vivoryon Therapeutics N.v. investor events
Find investor webinars, events, and replay context for Vivoryon Therapeutics N.v..
Alternate listings
VVY:EURONEXT
NL · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
05Y:GETTEX
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
05Y:TRADEGATE
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
0R3M:LSE
GB · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
05Y:FWB
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
A2QJV6:LSX
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
VVYA:AQUISEU
GB · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
VVYA:AQUISUK
GB · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
05Y:SWB
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
VVYA:TURQUOISE
GB · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
05Y:DUS
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.
05Y:HAM
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is A2QJV6:LS.